Skip to main content

ICD 10 CM Official Updates and Changes - 2022 - New Codes

The 2022 ICD-10-CM files below contain information on the ICD-10-CM updates for FY 2022. These 2022 ICD-10-CM codes are to be used for discharges occurring from October 1, 2021, through September 30, 2022, and for patient encounters occurring from October 1, 2021, through September 30, 2022.

Total changes - 243

  • New Codes  - 191 Additions
  • Deleted Codes - 25 Deletions
  • Revised Codes - 27 Revisions 

NEW CODE EFFECTIVE FROM OCTOBER 1ST, 2021 TO SEPTEMBER 30, 2022

Code Description

A79.82 Anaplasmosis [A. phagocytophilum]

C56.3 Malignant neoplasm of bilateral ovaries

C79.63 Secondary malignant neoplasm of bilateral ovaries

C84.7A Anaplastic large cell lymphoma, ALK-negative, breast

D55.21 Anemia due to pyruvate kinase deficiency

D55.29 Anemia due to other disorders of glycolytic enzymes

D75.83 Thrombocytosis

D75.838 Other thrombocytosis

D75.839 Thrombocytosis, unspecified

D89.44 Hereditary alpha tryptasemia

E75.244 Niemann-Pick disease type A/B

F32.A Depression, unspecified

F78.A Other genetic related intellectual disabilities

F78.A1 SYNGAP1-related intellectual disability

F78.A9 Other genetic related intellectual disability

G04.82 Acute flaccid myelitis

G44.86 Cervicogenic headache

G92.0 Immune effector cell-associated neurotoxicity syndrome

G92.00 Immune effector cell-associated neurotoxicity syndrome, grade unspecified

G92.01 Immune effector cell-associated neurotoxicity syndrome, grade 1

G92.02 Immune effector cell-associated neurotoxicity syndrome, grade 2

G92.03 Immune effector cell-associated neurotoxicity syndrome, grade 3

G92.04 Immune effector cell-associated neurotoxicity syndrome, grade 4

G92.05 Immune effector cell-associated neurotoxicity syndrome, grade 5

G92.8 Other toxic encephalopathy

G92.9 Unspecified toxic encephalopathy

I5A         Non-ischemic myocardial injury (non-traumatic)

K22.81 Esophageal polyp

K22.82 Esophagogastric junction polyp

K22.89 Other specified disease of esophagus

K31.A Gastric intestinal metaplasia

K31.A0 Gastric intestinal metaplasia, unspecified

K31.A1 Gastric intestinal metaplasia without dysplasia

K31.A11 Gastric intestinal metaplasia without dysplasia, involving the antrum

K31.A12 Gastric intestinal metaplasia without dysplasia, involving the body (corpus)

K31.A13 Gastric intestinal metaplasia without dysplasia, involving the fundus

K31.A14 Gastric intestinal metaplasia without dysplasia, involving the cardia

K31.A15 Gastric intestinal metaplasia without dysplasia, involving multiple sites

K31.A19 Gastric intestinal metaplasia without dysplasia, unspecified site

K31.A2 Gastric intestinal metaplasia with dysplasia

K31.A21 Gastric intestinal metaplasia with low grade dysplasia

K31.A22 Gastric intestinal metaplasia with high grade dysplasia

K31.A29 Gastric intestinal metaplasia with dysplasia, unspecified

L24.A Irritant contact dermatitis due to friction or contact with body fluids

L24.A0 Irritant contact dermatitis due to friction or contact with body fluids, unspecified

L24.A1 Irritant contact dermatitis due to saliva

L24.A2 Irritant contact dermatitis due to fecal, urinary or dual incontinence

L24.A9 Irritant contact dermatitis due friction or contact with other specified body fluids

L24.B Irritant contact dermatitis related to stoma or fistula

L24.B0 Irritant contact dermatitis related to unspecified stoma or fistula

L24.B1 Irritant contact dermatitis related to digestive stoma or fistula

L24.B2 Irritant contact dermatitis related to respiratory stoma or fistula

L24.B3 Irritant contact dermatitis related to fecal or urinary stoma or fistula

M31.10 Thrombotic microangiopathy, unspecified

M31.11 Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]

M31.19 Other thrombotic microangiopathy

M35.05 Sjogren syndrome with inflammatory arthritis

M35.06 Sjogren syndrome with peripheral nervous system involvement

M35.07 Sjogren syndrome with central nervous system involvement

M35.08 Sjogren syndrome with gastrointestinal involvement

M35.0A Sjogren syndrome with glomerular disease

M35.0B Sjogren syndrome with vasculitis

M35.0C Sjogren syndrome with dental involvement

M45.A Non-radiographic axial spondyloarthritis

M45.A0 Non-radiographic axial spondyloarthritis of unspecified sites in spine

M45.A1 Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region

M45.A2 Non-radiographic axial spondyloarthritis of cervical region

M45.A3 Non-radiographic axial spondyloarthritis of cervicothoracic region

M45.A4 Non-radiographic axial spondyloarthritis of thoracic region

M45.A5 Non-radiographic axial spondyloarthritis of thoracolumbar region

M45.A6 Non-radiographic axial spondyloarthritis of lumbar region

M45.A7 Non-radiographic axial spondyloarthritis of lumbosacral region

M45.A8 Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region

M45.AB Non-radiographic axial spondyloarthritis of multiple sites in spine

M54.50 Low back pain, unspecified

M54.51 Vertebrogenic low back pain

M54.59 Other low back pain

P00.82 Newborn affected by (positive) maternal group B streptococcus (GBS) colonization

P09.1 Abnormal findings on neonatal screening for inborn errors of metabolism

P09.2 Abnormal findings on neonatal screening for congenital endocrine disease

P09.3 Abnormal findings on neonatal screening for congenital hematologic disorders

P09.4 Abnormal findings on neonatal screening for cystic fibrosis

P09.5 Abnormal findings on neonatal screening for critical congenital heart disease

P09.6 Abnormal findings on neonatal screening for neonatal hearing loss

P09.8 Other abnormal findings on neonatal screening

P09.9 Abnormal findings on neonatal screening, unspecified

R05.1 Acute cough

R05.2 Subacute cough

R05.3 Chronic cough

R05.4 Cough syncope

R05.8 Other specified cough

R05.9 Cough, unspecified

R35.81 Nocturnal polyuria

R35.89 Other polyuria

R45.88 Nonsuicidal self-harm

R63.30 Feeding difficulties, unspecified

R63.31 Pediatric feeding disorder, acute

R63.32 Pediatric feeding disorder, chronic

R63.39 Other feeding difficulties

R79.83 Abnormal findings of blood amino-acid level

S06.A Traumatic brain compression and herniation

S06.A0 Traumatic brain compression without herniation

S06.A0XA Traumatic brain compression without herniation, initial encounter

S06.A0XD Traumatic brain compression without herniation, subsequent encounter

S06.A0XS Traumatic brain compression without herniation, sequela

S06.A1         Traumatic brain compression with herniation

S06.A1XA Traumatic brain compression with herniation, initial encounter

S06.A1XD Traumatic brain compression with herniation, subsequent encounter

S06.A1XS Traumatic brain compression with herniation, sequela

T40.71         Poisoning by, adverse effect of and underdosing of cannabis (derivatives)

T40.711         Poisoning by cannabis, accidental (unintentional)

T40.711A Poisoning by cannabis, accidental (unintentional), initial encounter

T40.711D Poisoning by cannabis, accidental (unintentional), subsequent encounter

T40.711S Poisoning by cannabis, accidental (unintentional), sequela

T40.712         Poisoning by cannabis, intentional self-harm

T40.712A Poisoning by cannabis, intentional self-harm, initial encounter

T40.712D Poisoning by cannabis, intentional self-harm, subsequent encounter

T40.712S Poisoning by cannabis, intentional self-harm, sequela

T40.713         Poisoning by cannabis, assault

T40.713A Poisoning by cannabis, assault, initial encounter

T40.713D Poisoning by cannabis, assault, subsequent encounter

T40.713S Poisoning by cannabis, assault, sequela

T40.714         Poisoning by cannabis, undetermined

T40.714A Poisoning by cannabis, undetermined, initial encounter

T40.714D Poisoning by cannabis, undetermined, subsequent encounter

T40.714S Poisoning by cannabis, undetermined, sequela

T40.715         Adverse effect of cannabis

T40.715A Adverse effect of cannabis, initial encounter

T40.715D Adverse effect of cannabis, subsequent encounter

T40.715S Adverse effect of cannabis, sequela

T40.716         Underdosing of cannabis

T40.716A Underdosing of cannabis, initial encounter

T40.716D Underdosing of cannabis, subsequent encounter

T40.716S Underdosing of cannabis, sequela

T40.72         Poisoning by, adverse effect of and underdosing of synthetic cannabinoids

T40.721         Poisoning by synthetic cannabinoids, accidental (unintentional)

T40.721A Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter

T40.721D Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter

T40.721S Poisoning by synthetic cannabinoids, accidental (unintentional), sequela

T40.722         Poisoning by synthetic cannabinoids, intentional self-harm

T40.722A Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter

T40.722D Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter

T40.722S Poisoning by synthetic cannabinoids, intentional self-harm, sequela

T40.723         Poisoning by synthetic cannabinoids, assault

T40.723A Poisoning by synthetic cannabinoids, assault, initial encounter

T40.723D Poisoning by synthetic cannabinoids, assault, subsequent encounter

T40.723S Poisoning by synthetic cannabinoids, assault, sequela

T40.724         Poisoning by synthetic cannabinoids, undetermined

T40.724A Poisoning by synthetic cannabinoids, undetermined, initial encounter

T40.724D Poisoning by synthetic cannabinoids, undetermined, subsequent encounter

T40.724S Poisoning by synthetic cannabinoids, undetermined, sequela

T40.725         Adverse effect of synthetic cannabinoids

T40.725A Adverse effect of synthetic cannabinoids, initial encounter

T40.725D Adverse effect of synthetic cannabinoids, subsequent encounter

T40.725S Adverse effect of synthetic cannabinoids, sequela

T40.726         Underdosing of synthetic cannabinoids

T40.726A Underdosing of synthetic cannabinoids, initial encounter

T40.726D Underdosing of synthetic cannabinoids, subsequent encounter

T40.726S Underdosing of synthetic cannabinoids, sequela

T80.82         Complication of immune effector cellular therapy

T80.82XA Complication of immune effector cellular therapy, initial encounter

T80.82XD Complication of immune effector cellular therapy, subsequent encounter

T80.82XS Complication of immune effector cellular therapy, sequela

U09                 Post COVID-19 condition

U09.9         Post COVID-19 condition, unspecified

Y35.899     Legal intervention involving other specified means, unspecified person injured

Y35.899A Legal intervention involving other specified means, unspecified person injured, initial encounter

Y35.899D Legal intervention involving other specified means, unspecified person injured, subsequent encounter

Y35.899S Legal intervention involving other specified means, unspecified person injured, sequela

Z55.5         Less than a high school diploma

Z58         Problems related to physical environment

Z58.6 Inadequate drinking-water supply

Z59.00 Homelessness unspecified

Z59.01 Sheltered homelessness

Z59.02 Unsheltered homelessness

Z59.41 Food insecurity

Z59.48 Other specified lack of adequate food

Z59.81 Housing instability, housed

Z59.811 Housing instability, housed, with risk of homelessness

Z59.812 Housing instability, housed, homelessness in past 12 months

Z59.819 Housing instability, housed unspecified

Z59.89 Other problems related to housing and economic circumstances

Z71.85 Encounter for immunization safety counseling

Z91.014 Allergy to mammalian meats

Z91.51 Personal history of suicidal behavior

Z91.52 Personal history of nonsuicidal self-harm

Z92.85 Personal history of cellular therapy

Z92.850 Personal history of Chimeric Antigen Receptor T-cell therapy

Z92.858 Personal history of other cellular therapy

Z92.859 Personal history of cellular therapy, unspecified

Z92.86 Personal history of gene therapy


Popular posts from this blog

Telehealth Update Medicare - 2022

The listed CPT codes are covered in telehealth and changes are effective from dated on June 16, 2022 Medicare telehealth services require that the services occur over real-time audio and visual interactive telecommunications. For purposes of diagnosis, evaluation, or treatment of mental health disorders. If the patient doesn’t have the technical capacity or the availability of real-time audio and visual interactive telecommunications, or they don’t consent to the use of real-time video technology, we allow audio-only communication for telehealth mental health services to established patients located in their homes. After the PHE ends, Telehealth Mental Health services may include new or established patients so long as an in-person, face-to-face, non-telehealth service takes place within 6 months of the telehealth mental health services. This means that all telehealth mental health patients should have had a first in-person visit no later than 6 months after the PHE. After the PHE and a

CPT Changes - New CPT Codes '2022

Glimpses of CPT Codes Updates - Effective from January 1st 2022 There are more than 400 codes are changes in 2022 from AMA. Total number codes are changed 405 and including of followings, New Codes -  249  Revised Codes - 93  Deleted Codes - 63 More than 40% of the editorial changes are tried to new technology services described in Category III CPT codes and the continued expansion of the proprietary laboratory analyses section of the CPT code set. Five new CPT codes are created for therapeutic remote monitoring codes 98975, 98976, 98977, 98980 and 98981 to increasingly important avenue of patient care especially during the COVID-19 pandemic. Five new CPT codes are created for complex care management codes 99424, 99425, 99426, 99427 and 99437 a nd there are some changes in chronic care management CPT codes as well. Six new CPT codes are created for Cardiac Catheterization codes 93593, 93594, 93595, 93596, 93597 and 93598 for congenital heart defects. Also, there are some changes in ele

Annual Preventive and Wellness Visit Service

Preventive Service Codes The annual preventive exam is a periodic, comprehensive preventive medicine evaluation (or reevaluation) and management of the patient. The CPT Code selection is based on whether the patient is receiving an initial visit -"New Patient" or a periodic - "Established Patient" preventive service, as well as the patient’s age. Initial Visits - 99381, 99382, 99383, 99384, 99385, 99386, 99387 Subsequent Visits - 99391, 99392, 99393, 99394, 99395, 99396, 99397 The Medicare insurance would be covered by "G" codes instead of the above codes. The details below, Welcome to Medicare - G0402 (Within the one year from the patient enrolled in Medicare) Initial Annual Wellness Visit - G0438 (After the 1st year of enrollment) Subsequent Annual Wellness Visit - G0439 Initial Visits Initial comprehensive preventive medicine evaluation and management of an individual including an" age and gender appropriate history, examination, counseling/anticip